News Talk 94.1/AM 1600 Where The Upper Cumberland Talks
The acquisition aims to diversify AbbVie beyond its top-selling drug Humira, which will soon lose patent protection Source
Sunday, September 22, 2024
The acquisition aims to diversify AbbVie beyond its top-selling drug Humira, which will soon lose patent protection Source
If you need assistance accessing our public file, please contact Larry Stone at (931) 528-6064.